Get to Know Bio-Techne

Headquarters: Minneapolis, Minnesota
Global Presence: 34 locations, 3,000+ employees
Product Portfolio: 500,000+ reagents, instruments, and diagnostics

Bio-Techne is a global leader in the development, manufacturing, and supply of high-quality reagents, precision diagnostics, and analytical instruments. Founded as R&D Systems in 1981 and rebranded as Bio-Techne in 2014, the company has grown through strategic acquisitions, innovation, and global expansion. In fiscal year 2023, Bio-Techne reported net sales exceeding $1.1 billion. Its key brands include ACD, Asuragen, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems, and Tocris Bioscience.

Our Mission & Commitment

Support scientific discovery with reliable, high-quality products

Maintain strict quality control and comprehensive customer support

Combine multidisciplinary expertise to offer a full portfolio of life science solutions

Company Origins and Growth

Bio-Techne’s roots date back to 1976 with R&D Systems in Minnesota. The company’s initial focus was hematology controls and calibrators for clinical diagnostics. By 1985, R&D Systems released TGF-beta 1, the world’s first commercially available cytokine, marking the company’s entry into biotechnology. This success led to the creation of the Growth Factor (Biotechnology) Division and expansion into recombinant proteins, monoclonal and polyclonal antibodies, and enzyme-linked immunosorbent assays (ELISAs).

Strategic Expansion

Bio-Techne has steadily expanded globally, with subsidiaries across Europe, Asia, and the Americas. Key milestones include:

1993–1998: Establishment of R&D Systems Europe and acquisition of Genzyme’s research products

2005–2011: Acquisition of Fortron Bioscience, BiosPacific, Boston Biochem, and Tocris Bioscience, enhancing capabilities in antibodies, ubiquitin-related research tools, and pharmacological reagents

2013–2023: Strategic acquisitions of Bionostics, Cliniqa, Zephyrus, Asuragen, Namocell, and Lunaphore, further broadening Bio-Techne’s diagnostic and life sciences offerings

Research and Product Expertise

Today, Bio-Techne’s catalog exceeds 24,000 products, 95% of which are manufactured in-house. Core areas include:

Cytokines and growth factors for biomedical research

Immunoassays and multiplex platforms

Monoclonal and polyclonal antibodies

Biologically active compounds and small molecules

Cell selection kits, multicolor flow cytometry, and stem cell tools

Clinical hematology controls and instruments

Global Impact

Bio-Techne’s integrated approach combines high-quality products, innovative technologies, and expert support to enable breakthroughs in research and clinical diagnostics. With a commitment to advancing science, the company supports the development of novel therapies, enhances understanding of biological processes, and empowers the life sciences community worldwide.

Bio-Techne continues to serve as a trusted partner for researchers, clinicians, and OEMs, providing the tools and expertise needed to accelerate discovery and improve patient care.

Go to Top